TiumBio Co Ltd
KOSDAQ:321550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
KR |
|
SY Holdings Group Ltd
HKEX:6069
|
CN |
|
Sievi Capital Oyj
LSE:0NQK
|
FI |
|
Unity Enterprise Holdings Ltd
HKEX:2195
|
HK |
TiumBio Co Ltd
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.